329 related articles for article (PubMed ID: 26508681)
1. Hyperphosphatemia in Dialysis Patients: Beyond Nonadherence to Diet and Binders.
Sherman RA
Am J Kidney Dis; 2016 Feb; 67(2):182-6. PubMed ID: 26508681
[TBL] [Abstract][Full Text] [Related]
2. Adherence to phosphate binders in hemodialysis patients: prevalence and determinants.
Van Camp YP; Vrijens B; Abraham I; Van Rompaey B; Elseviers MM
J Nephrol; 2014 Dec; 27(6):673-9. PubMed ID: 24563270
[TBL] [Abstract][Full Text] [Related]
3. Phosphate balance in ESRD: diet, dialysis and binders against the low evident masked pool.
Galassi A; Cupisti A; Santoro A; Cozzolino M
J Nephrol; 2015 Aug; 28(4):415-29. PubMed ID: 25245472
[TBL] [Abstract][Full Text] [Related]
4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
5. Daily dietary phosphorus intake variability and hemodialysis patient adherence to phosphate binder therapy.
Tao X; Zhang H; Yang Y; Zhang C; Wang M
Hemodial Int; 2019 Oct; 23(4):458-465. PubMed ID: 31328873
[TBL] [Abstract][Full Text] [Related]
6. [Hyperphosphatemia in dialysis: which binder?].
Alfieri C; Malberti F; Mazzaferro S; Gallieni M; Russo D; Messa P; Cozzolino M
G Ital Nefrol; 2018 Sep; 35(5):. PubMed ID: 30234231
[TBL] [Abstract][Full Text] [Related]
7. Interventional study to improve adherence to phosphate binder treatment in dialysis patients.
Hjemås BJ; Bøvre K; Mathiesen L; Lindstrøm JC; Bjerknes K
BMC Nephrol; 2019 May; 20(1):178. PubMed ID: 31101020
[TBL] [Abstract][Full Text] [Related]
8. Phosphate control in chronic uremia: don't forget diet.
Cupisti A; Morelli E; D'Alessandro C; Lupetti S; Barsotti G
J Nephrol; 2003; 16(1):29-33. PubMed ID: 12649532
[TBL] [Abstract][Full Text] [Related]
9. Oral phosphate binders in CKD - is calcium the (only) answer?
Goldsmith D; Covic A
Clin Nephrol; 2014 Jun; 81(6):389-95. PubMed ID: 25017668
[TBL] [Abstract][Full Text] [Related]
10. [Phosphate binders].
Heeb RM
Med Monatsschr Pharm; 2016 Jun; 39(6):255-60. PubMed ID: 27439258
[TBL] [Abstract][Full Text] [Related]
11. Use of nicotinamide to treat hyperphosphatemia in dialysis patients.
Lenglet A; Liabeuf S; Guffroy P; Fournier A; Brazier M; Massy ZA
Drugs R D; 2013 Sep; 13(3):165-73. PubMed ID: 24000048
[TBL] [Abstract][Full Text] [Related]
12. Dialytic phosphate removal: a modifiable measure of dialysis efficacy in automated peritoneal dialysis.
Schmitt CP; Borzych D; Nau B; Wühl E; Zurowska A; Schaefer F
Perit Dial Int; 2009; 29(4):465-71. PubMed ID: 19602613
[TBL] [Abstract][Full Text] [Related]
13. Management of hyperphosphatemia.
Kuhlmann MK
Hemodial Int; 2006 Oct; 10(4):338-45. PubMed ID: 17014508
[TBL] [Abstract][Full Text] [Related]
14. Effect of gastric acid suppression with pantoprazole on the efficacy of calcium carbonate as a phosphate binder in haemodialysis patients.
Cervelli MJ; Shaman A; Meade A; Carroll R; McDonald SP
Nephrology (Carlton); 2012 Jul; 17(5):458-65. PubMed ID: 22471559
[TBL] [Abstract][Full Text] [Related]
15. Salivary glands: a new player in phosphorus metabolism.
Savica V; Calò LA; Santoro D; Monardo P; Santoro G; Muraca U; Davis PA; Bellinghieri G
J Ren Nutr; 2011 Jan; 21(1):39-42. PubMed ID: 21195917
[TBL] [Abstract][Full Text] [Related]
16. More dietetic time, better outcome? A randomized prospective study investigating the effect of more dietetic time on phosphate control in end-stage kidney failure haemodialysis patients.
Morey B; Walker R; Davenport A
Nephron Clin Pract; 2008; 109(3):c173-80. PubMed ID: 18663331
[TBL] [Abstract][Full Text] [Related]
17. Use of phosphate binders in chronic kidney disease.
Ketteler M; Biggar PH
Curr Opin Nephrol Hypertens; 2013 Jul; 22(4):413-20. PubMed ID: 23736841
[TBL] [Abstract][Full Text] [Related]
18. Management of phosphate abnormalities in hemodialysis patients: Findings from Malaysia.
Mohamed Koya SNM
Saudi J Kidney Dis Transpl; 2019; 30(3):670-677. PubMed ID: 31249232
[TBL] [Abstract][Full Text] [Related]
19. Improvement in Hyperphosphatemia Using Phosphate Education and Planning Talks.
Brauer A; Waheed S; Singh T; Maursetter L
J Ren Nutr; 2019 Mar; 29(2):156-162. PubMed ID: 30087012
[TBL] [Abstract][Full Text] [Related]
20. Dose-response and efficacy of ferric citrate to treat hyperphosphatemia in hemodialysis patients: a short-term randomized trial.
Dwyer JP; Sika M; Schulman G; Chang IJ; Anger M; Smith M; Kaplan M; Zeig S; Koury MJ; Blumenthal SS; Lewis JB;
Am J Kidney Dis; 2013 May; 61(5):759-66. PubMed ID: 23369827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
